chr12-10986745-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_176890.2(TAS2R50):āc.116A>Gā(p.Lys39Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000186 in 1,612,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176890.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAS2R50 | NM_176890.2 | c.116A>G | p.Lys39Arg | missense_variant | 1/1 | ENST00000506868.1 | |
PRH1-TAS2R14 | NM_001316893.2 | c.141-13024A>G | intron_variant | ||||
PRH1-PRR4 | NR_037918.2 | n.478-13024A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAS2R50 | ENST00000506868.1 | c.116A>G | p.Lys39Arg | missense_variant | 1/1 | NM_176890.2 | P1 | ||
ENST00000703543.1 | c.-125-13024A>G | intron_variant | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152122Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 249738Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135030
GnomAD4 exome AF: 0.0000178 AC: 26AN: 1460390Hom.: 0 Cov.: 34 AF XY: 0.0000165 AC XY: 12AN XY: 726430
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152122Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74308
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 28, 2022 | The c.116A>G (p.K39R) alteration is located in exon 1 (coding exon 1) of the TAS2R50 gene. This alteration results from a A to G substitution at nucleotide position 116, causing the lysine (K) at amino acid position 39 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at